Trials Delivery Framework

Image of five older people standing together in a park, talking and laughing

Our Trials Delivery Framework is establishing an engine for testing new treatments for dementia. Its aim is to bring the right people to the right place for the right project.

This precision-matching of volunteers to early-phase trials based on detailed genetic and observed characteristics will ensure that researchers testing therapies and interventions can understand quickly and robustly what works – and what doesn't. Study participants will be recruited both from pre-clinical registries and through clinical referrals.

Find out more in our Q&A with the Trials Delivery Framework's lead researcher, Dr Vanessa Raymont.

Our volunteer registries

DPUK runs two pre-clinical registries of public volunteers: Great Minds and the Clinical Studies Register. Study sponsors can use these resources to find the right participants for their project – whether it's an experimental study or a clinical trial.

Clinical register and sites

The clinical arm of the Trials Delivery Framework contains 30 UK sites for clinical trial recruitment and delivery, at NHS and academic research sites, incorporating all the UK brain health clinics across the UK and beyond. By developing such an extensive network in both research active academic sites and less research focused NHS Trusts with a broad geographic spread, we aim to provide more representative, real world data and populations to trials. We are now also recruiting primary care practices to our network to provide even further reach for trial recruitment. Data from these clinical sites is being centrally managed within the DPUK Data Portal, allowing us to create a large and very scalable data set of blood, clinical imaging and cognitive data across multiple UK clinical sites for efficient and effective recruitment to clinical trials.

Researchers at Oxford University are recruiting volunteers aged 50+ who have either mild cognitive impairment (MCI) or early-stage dementia, as well as neurologically healthy people as an essential comparison to those with memory impairment.

Great Minds is a register of over 9,000 highly characterised research volunteers from existing DPUK-affiliated cohort studies and the nationwide Join Dementia Research register. These volunteers undergo regular additional assessment of memory and mood, and have expressed their willingness to take part in experimental medicine studies and clinical trials for dementia.

Find out more on the Great Minds website.

Anxiety and depression are more important predictors of cognitive decline than factors such as cardiovascular disease or diabetes, new analysis has shown.

Our Clinical Studies Register comprises more than 58,000 research participants who have already undergone extensive characterisation and have pre-existing consent for re-contact through their parent DPUK cohort.

By combining detailed phenotyping and, where available, genomic data from cohorts, the Clinical Studies Register enables risk stratification per hypothesis at a level of detail and convenience that would not otherwise be available.

Run a study with our volunteers

We have developed interactive feasibility tools to enable researchers to determine the number of Great Minds or Clinical Studies Register members that meet their study's requirements. You can register for and use this service via the DPUK Data Portal.

If you already know you would like to recruit participants from Great Minds or the Clinical Studies Register, please sign up for a researcher account on our customer relationship management system. Once your registration has been approved, you'll be able to log in and apply for volunteers using the same site.

Our partners

The Trials Delivery Framework is closely aligned with DPUK's Experimental Medicine Incubator,stratification and case validation for pre-clinical experimental studies. It operates in conjunction with the NIHR's Join Dementia Research initiative and other UK-based and international partners such as the Brain Health Coalition of Brain Health Centres, the NIHR Dementia Translational Research Collaboration Trial Network, the Dame Barbara Windsor Dementia Mission, The Davos Alzheimer's Collaborative and the Global Alzheimer's Platform.